MX337348B - Metodos para purificar virus utilizando cromatografia de permeacion en gel. - Google Patents

Metodos para purificar virus utilizando cromatografia de permeacion en gel.

Info

Publication number
MX337348B
MX337348B MX2013012627A MX2013012627A MX337348B MX 337348 B MX337348 B MX 337348B MX 2013012627 A MX2013012627 A MX 2013012627A MX 2013012627 A MX2013012627 A MX 2013012627A MX 337348 B MX337348 B MX 337348B
Authority
MX
Mexico
Prior art keywords
methods
gel permeation
permeation chromatography
purifying viruses
viruses
Prior art date
Application number
MX2013012627A
Other languages
English (en)
Spanish (es)
Other versions
MX2013012627A (es
Inventor
Matthew C Coffey
Allison Hagerman
Roxna Kapadia
Sarah Serl
Original Assignee
Oncolytics Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc
Publication of MX2013012627A publication Critical patent/MX2013012627A/es
Publication of MX337348B publication Critical patent/MX337348B/es

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/42Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424Elution mode
    • B01D15/426Specific type of solvent
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02Separating microorganisms from their culture media
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12051Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicinal Preparation (AREA)
MX2013012627A 2011-04-29 2012-04-27 Metodos para purificar virus utilizando cromatografia de permeacion en gel. MX337348B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161480561P 2011-04-29 2011-04-29
PCT/CA2012/000406 WO2012145837A1 (en) 2011-04-29 2012-04-27 Methods of purifying viruses using gel permeation chromatography

Publications (2)

Publication Number Publication Date
MX2013012627A MX2013012627A (es) 2014-05-13
MX337348B true MX337348B (es) 2016-02-29

Family

ID=47067091

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013012627A MX337348B (es) 2011-04-29 2012-04-27 Metodos para purificar virus utilizando cromatografia de permeacion en gel.

Country Status (15)

Country Link
US (1) US20120273424A1 (https=)
EP (1) EP2702147B1 (https=)
JP (1) JP6029651B2 (https=)
KR (2) KR20140024406A (https=)
CN (1) CN103492557B (https=)
AU (1) AU2012248082B2 (https=)
CA (1) CA2832367A1 (https=)
DK (1) DK2702147T3 (https=)
EA (1) EA201391605A1 (https=)
ES (1) ES2822199T3 (https=)
IL (1) IL228491A (https=)
MX (1) MX337348B (https=)
SG (1) SG194449A1 (https=)
TW (1) TW201307561A (https=)
WO (1) WO2012145837A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011336413B2 (en) * 2010-12-02 2015-01-22 Oncolytics Biotech Inc. Liquid viral formulations
MX349294B (es) 2010-12-02 2017-07-21 Oncolytics Biotech Inc Formulaciones virales liofilizadas.
BR112015031541A2 (pt) 2013-06-17 2017-07-25 De Staat Der Nederlanden Vert Door De Mini Van Vws Miniie Van Volksgezondheid Welzijn En Sport métodos para o impedimento da agregação de componentes virais
US11999975B2 (en) 2018-07-04 2024-06-04 Probiogen Ag Method for purifying an enveloped virus
CN111812313B (zh) * 2020-06-22 2021-10-08 北京生物制品研究所有限责任公司 铝佐剂吸附型新型冠状病毒灭活疫苗中抗原的解离方法
CN114544815B (zh) * 2022-03-01 2023-10-27 中牧实业股份有限公司 一种山羊痘病毒的定量检测方法
CN116718524B (zh) * 2023-06-26 2025-11-07 西安交通大学 一种基于细胞膜色谱技术的病毒颗粒检测方法
HUP2400154A1 (hu) * 2024-02-29 2025-09-28 Pecsi Tudomanyegyetem Elúciós oldat és tisztítási eljárás

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
DE69029765T2 (de) * 1989-07-24 1997-05-15 Bayer Ag Stabilisierung von hochgereinigten Proteinen
JP3863559B2 (ja) * 1994-05-16 2006-12-27 メルク エンド カンパニー インコーポレーテッド 乳頭腫ウィルスワクチン
KR100912362B1 (ko) * 1998-02-17 2009-08-19 쉐링 코포레이션 바이러스 제제의 정제방법
DK2253701T3 (da) 2001-03-16 2014-10-20 Oncolytics Biotech Inc Fremgangsmåde til ekstraktion af en virus fra en cellekultur
CA2482512C (en) * 2002-04-30 2011-09-20 Oncolytics Biotech Inc. Improved viral purification methods
US7901921B2 (en) * 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods
EP1878791A1 (en) * 2006-07-11 2008-01-16 Bia Separations D.O.O. Method for influenza virus purification
EP2055311B1 (en) * 2006-08-07 2017-06-21 The Chemo-Sero-Therapeutic Research Institute Process for preparing live smallpox vaccine
JP5577103B2 (ja) * 2007-03-12 2014-08-20 オンコリティクス バイオテク,インコーポレーテッド 改変配列を有するレオウイルス
NZ585500A (en) * 2007-11-12 2012-06-29 Theraclone Sciences Inc Antibodies which bind to an epitope in the extracellular domain of the matrix 2 ectodomain polypeptide of an influenza virus
US8227577B2 (en) * 2007-12-21 2012-07-24 Hoffman-La Roche Inc. Bivalent, bispecific antibodies
MX349294B (es) * 2010-12-02 2017-07-21 Oncolytics Biotech Inc Formulaciones virales liofilizadas.
AU2011336413B2 (en) * 2010-12-02 2015-01-22 Oncolytics Biotech Inc. Liquid viral formulations

Also Published As

Publication number Publication date
KR20190026059A (ko) 2019-03-12
MX2013012627A (es) 2014-05-13
JP2014516515A (ja) 2014-07-17
KR102151890B1 (ko) 2020-09-03
IL228491A (en) 2017-05-29
EP2702147B1 (en) 2020-07-15
SG194449A1 (en) 2013-12-30
AU2012248082A1 (en) 2013-05-09
IL228491A0 (en) 2013-12-31
AU2012248082B2 (en) 2015-08-20
WO2012145837A1 (en) 2012-11-01
CN103492557A (zh) 2014-01-01
ES2822199T3 (es) 2021-04-29
KR20140024406A (ko) 2014-02-28
US20120273424A1 (en) 2012-11-01
EA201391605A1 (ru) 2014-02-28
EP2702147A1 (en) 2014-03-05
EP2702147A4 (en) 2014-11-05
CN103492557B (zh) 2015-07-29
TW201307561A (zh) 2013-02-16
CA2832367A1 (en) 2012-11-01
DK2702147T3 (da) 2020-09-28
JP6029651B2 (ja) 2016-11-24

Similar Documents

Publication Publication Date Title
SG194449A1 (en) Methods of purifying viruses using gel permeation chromatography
MX392274B (es) Cartuchos utiles en limpieza de soluciones de dialisis.
WO2016054598A3 (en) Antibodies that bind ebola glycoprotein and uses thereof
WO2013078170A8 (en) Purification of anti-c-met antibodies
MX2015011199A (es) Agentes terapéuticos de csf1.
EP3971286A3 (en) Nipah virus envelope pseudotyped lentiviruses and methods of use
PH12013501683A1 (en) Yeast-based therapeutic for chronic hepatitis b infection
ECSP13013060A (es) Composiciones de nucleasa terapéuticas y métodos
MX378747B (es) Complejos de proteínas de citomegalovirus.
MX2010004892A (es) Terapia de combinacion para tratar infecciones virales persistentes.
IN2014KN02831A (https=)
MX2014010754A (es) Composiciones que comprenden inmunoglobulinas de tipo secretor.
SI3660032T1 (sl) Postopki zajemanja in čiščenja beljakovin, izraženih v nesesalskem sistemu
WO2013028334A3 (en) Use of small molecules in methods for purification of biomolecules
MX2019006568A (es) Eliminacion de ligandos lixiviados de purificacion de afinidad.
TN2013000388A1 (en) Anticoagulant antidotes
BR112016022214A2 (pt) rnase para uso no tratamento ou prevenção de infecções virais
IT1399575B1 (it) Sistema di aggancio perfezionato per settori di prolunga su banco di stesa per vibrofinitrice stradale, banco di stesa e vibrofinitrice comprendenti detto sistema di aggancio.
MX2018003080A (es) Cartuchos utiles en soluciones de dialisis de limpieza.
EA201590778A1 (ru) ОЧИСТКА КОМБИНИРОВАННОЙ ГАЛАКТОЦЕРЕБРОЗИД-β-ГАЛАКТОЗИДАЗЫ ЧЕЛОВЕКА (rhGALC)
PE20170586A1 (es) Nuevo uso de n,n-bis-2-mercaptoetil isoftalamida
WO2014160098A3 (en) Bordetella specific human recombinant antibodies and uses thereof
BR112014023946A8 (pt) Um sistema de elemento de desgaste
WO2012164003A3 (de) Solareinrichtung mit reflektorvorrichtung und reflektorvorrichtung
PH12014501285B1 (en) Liquid activation system

Legal Events

Date Code Title Description
FG Grant or registration